Atlas Trials

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Clinical trial NCT01928459 · COMPLETED

Trial details

NCT number
NCT01928459
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsMetastatic Solid Tumors
Start date
2013-10-01
Primary completion
2016-08-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.